Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Mesenchymal stem cells have been recently described to localize to breast carcinomas, where they integrate into the tumour-associated stroma. However, the involvement of mesenchymal stem cells (or their derivatives) in tumour pathophysiology has not been addressed. Here, we demonstrate that bone-marrow-derived human mesenchymal stem cells, when mixed with otherwise weakly metastatic human breast carcinoma cells, cause the cancer cells to increase their metastatic potency greatly when this cell mixture is introduced into a subcutaneous site and allowed to form a tumour xenograft. The breast cancer cells stimulate de novo secretion of the chemokine CCL5 (also called RANTES) from mesenchymal stem cells, which then acts in a paracrine fashion on the cancer cells to enhance their motility, invasion and metastasis. This enhanced metastatic ability is reversible and is dependent on CCL5 signalling through the chemokine receptor CCR5. Collectively, these data demonstrate that the tumour microenvironment facilitates metastatic spread by eliciting reversible changes in the phenotype of cancer cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MSC can be mobilized and recruited to active tumor sites, where they can incorporate into the tumor’s microenvironment [5, 68, 100–103].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [100]
In the citing paper
“CCL5 can be secreted by both BM-MSC and ASC [100, 144] and displays pro-proliferative activities on breast cancer cell lines [145, 146].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [100]
In the citing paper
“Another MSC-secreted pro-metastasis cytokine, CCL5 (RANTES), can be secreted upon interaction with cancer cells and is associated with tumor progression and invasion in various cancers [73, 87, 100, 142–144].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [100]
In the citing paper
“The injection of bone marrow-derived MSCs into tumour-bearing mice has demonstrated that they can become CAFs40”
From A framework for advancing our understanding of cancer-associated fibroblasts (2020) · cites this paper as [40]
In the citing paper
“CAFs comprise the majority of cell types within the TME, and their reciprocal interactions with cancer cells have been well documented (Whiteside, 2008; Hazlehurst et al., 2003; Karnoub et al., 2007).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Karnoub et al., 2007
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Self-citationCreation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
Self-citationCancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
Bissell, M. J., & Radisky, D. (2001) · Nature Reviews Cancer · doi:10.1038/35094059 · Cited by 2,180
Molecular characterization of the tumor microenvironment in breast cancer
Allinen, M., Beroukhim, R., Cai, L., Brennan, C., Lahti-Domenici, J., Huang, H., Porter, D., Hu, M., Chin, L., Richardson, A., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.010 · Cited by 1,299
Self-citationHuman Bone Marrow–Derived Mesenchymal Stem Cells in the Treatment of Gliomas
Nakamizo, A., Marini, F., Amano, T., Khan, A., Studeny, M., Gumin, J., Chen, J., Hentschel, S., Vecil, G., Dembinski, J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1874 · Cited by 1,035
(2002) · PubMed · Cited by 903
Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells
Elenbaas, B., Spirio, L., Koerner, F., Fleming, M. D., Zimonjic, D. B., Donaher, J. L., Popescu, N. C., Hahn, W. C., & Weinberg, R. A. (2001) · Genes & Development · doi:10.1101/gad.828901 · Cited by 878
Self-citation
Cited by
Items 501–600 of 1,024
Mandel, K., Yang, Y., Schambach, A., Glage, S., Otte, A., & Hass, R. (2013) · Stem Cells and Development · doi:10.1089/scd.2013.0249 · Cited by 133
“Vice versa, breast cancer cells respond to these compounds by the expression of distinct receptors such as CCR5 and CXCR4, which promote signals for proliferation and migration of the tumor cells on further corresponding stimuli such as CCL5 and SDF-1 [23,56–58].”
Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer
Aldinucci, D., & Casagrande, N. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051477 · Cited by 151
Jan, N., Madni, A., Khan, S., Shah, H., Akram, F., Khan, A., Ertas, D., Bostanudin, M. F., Contag, C. H., Ashammakhi, N. A., et al. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10441 · Cited by 150
“Treatment with DCNPs without O2 supply displayed large-scale hypoxia distribution in tumor and low fluorescence intensity of DOX.”
BackgroundMethodInfluentialThe mesenchymal stromal cell contribution to homeostasis
Valtieri, M., & Sorrentino, A. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21521 · Cited by 151
“…present, with similar but not identical features in cord blood, adult peripheral blood (mobilized or not), and adipose tissue (Wagner et al., 2005; Kassis et al., 2006; Mansilla et al., 2006), more stringent isolation procedures, characterizations, and assays are recently emerging to improve…”
BackgroundModeling sarcomagenesis using multipotent mesenchymal stem cells
Rodríguez, R., Rubio, R., & Menéndez, P. R. (2011) · Cell Research · doi:10.1038/cr.2011.157 · Cited by 149
Tumor microenvironment-mediated chemoresistance in breast cancer
velaei, K., Samadi, N., Barazvan, B., & Soleimani Rad, J. (2016) · The Breast · doi:10.1016/j.breast.2016.09.002 · Cited by 138
Ryder, M., Gild, M., Hohl, T. M., Pamer, E., Knauf, J., Ghossein, R., Joyce, J. A., & Fagin, J. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054302 · Cited by 138
“In mouse models, CAFs facilitate malignant transformation [37], stimulate tumor angiogenesis and remodel the extracellular matrix to enhance tumor cell invasion [38] and metastases [39].”
Background(2011) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-385859-7.00003-3 · Cited by 136
“, 2005) and mesenchymal (Hurst and Welch, 2007; Karnoub et al., 2007; Kitamura et al., 2007; Ojalvo et al., 2010; Patsialou et al., 2009; Wyckoff et al., 2007; Yan et al., 2010) stem cells.”
BackgroundRecent advances in mesenchymal stem cell membrane-coated nanoparticles for enhanced drug delivery
Wang, M., Xin, Y., Cao, H., Li, W., Hua, Y., Webster, T. J., Zhang, C., Tang, W., & Liu, Z. (2021) · Biomaterials Science · doi:10.1039/d0bm01164a · Cited by 141
Microenvironmental regulation of cancer metastasis by miRNAs
Zhang, Y., Yang, P., & Wang, X. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.09.007 · Cited by 147
Veirman, K. D., Wang, J., Xu, S., Leleu, X. P., Himpe, E., Maes, K., Bruyne, E. D., Valckenborgh, E. V., Vanderkerken, K., Menu, E., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.04.024 · Cited by 147
Avnet, S., Di Pompo, G., Chano, T., Errani, C., Ibrahim-Hashim, A., Gillies, R. J., Donati, D. M., & Baldini, N. (2017) · International Journal of Cancer · doi:10.1002/ijc.30540 · Cited by 132
Sgroi, D. C. (2009) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092306 · Cited by 149
Breast surgery for metastatic breast cancer
Tosello, G. T., Torloni, M. R., Mota, B. S., Neeman, T. M., & Riera, R. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011276.pub2 · Cited by 146
Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy
Morein, D., Erlichman, N., & Ben‐Baruch, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00952 · Cited by 148
“Also, the study by Weinberg and colleagues demonstrated that CCL5 released by MSCs has acted through CCR5 to promote breast tumor cell migration, invasion and metastasis in animal studies (164).”
Yoshida, G. J., Azuma, A., Miura, Y., & Orimo, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092256 · Cited by 126
“Injection of MSCs with carcinoma cells into immunodeficient mice also results in enhanced tumor growth and metastasis presumably through differentiation into tumor-promoting CAFs [57].”
BackgroundAcquisition of new tumor cell properties by MSC-derived exosomes
YANG, Y., BUCAN, V., BAEHRE, H., VON DER OHE, J., OTTE, A., & HASS, R. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3001 · Cited by 129
Autologous Fat Grafting: The Science Behind the Surgery
Zielins, E. R., Brett, E. A., Longaker, M. T., & Wan, D. C. (2016) · Aesthetic Surgery Journal · doi:10.1093/asj/sjw004 · Cited by 144
Ayuzawa, R., Doi, C., Rachakatla, R. S., Pyle, M. M., Maurya, D. K., Troyer, D., & Tamura, M. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.011 · Cited by 133
“In contrast to the UCMSC-dependent growth attenuation of cancer cells, bone marrow-derived MSC have been shown to stimulate growth of melanoma cells in a syngeneic tumor model [27] and stimulate motility and metastatic ability [28].”
ResultWeitzenfeld, P., & Ben‐Baruch, A. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.10.006 · Cited by 143
“Of note, stroma-derived CCL5 may be especially important in inducing pro-malignancy effects, as demonstrated by the fact that breast tumor cells induced the release of CCL5 by MSCs, which then promoted migration, invasion and metastasis of CCR5-expressing tumor cells [101].”
BackgroundF-box protein FBXW7 inhibits cancer metastasis in a non-cell-autonomous manner
Yumimoto, K., Akiyoshi, S., Ueo, H., Sagara, Y., Onoyama, I., Ueo, H., Ohno, S., Mori, M., Mimori, K., & Nakayama, K. I. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78782 · Cited by 143
“…and monocytic myeloid-derived suppressor cells (G-MDSCs and Mo-MDSCs, respectively) (3–6), macrophages (7–10), BM-derived stromal cells (BMSCs) (11, 12), hematopoietic progenitor cells (HPCs) (13), and endothelial progenitor cells (EPCs) (14) — play pivotal roles in promoting metastasis,…”
Critical Role of STAT3 in IL-6–Mediated Drug Resistance in Human Neuroblastoma
Ara, T., Nakata, R., Sheard, M. A., Shimada, H., Buettner, R., Groshen, S. G., Ji, L., Yu, H., Jove, R., Seeger, R. C., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2353 · Cited by 149
“The acquisition of these properties occurs through complex interactions between tumor cells and a variety of stromal cells such as carcinoma-associated fibroblasts, endothelial cells, adipocytes, myofibroblasts, mesenchymal cells, and innate and adaptative immune cells (2-5).”
BackgroundChanda, D., Kumar, S., & Ponnazhagan, S. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22701 · Cited by 127
“MSCs have been shown to promote tumor growth and metastasis in various studies [Karnoub et al., 2007].”
BackgroundCollagen Type XI Alpha 1 (COL11A1): A Novel Biomarker and a Key Player in Cancer
Nallanthighal, S., Heiserman, J. P., & Cheon, D. (2021) · Cancers · doi:10.3390/cancers13050935 · Cited by 143
Calvo, F., Ranftl, R., Hooper, S., Farrugia, A. J., Moeendarbary, E., Bruckbauer, A., Batista, F., Charras, G., & Sahai, E. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.11.052 · Cited by 142
“Cell Rep of BORG genes in patient datasets (Finak et al., 2008; Karnoub et al., 2007) revealed that CDC42EP3 was consistently upregulated in the stromal compartment of human breast carcinoma compared to normal tissue samples (Figure S1G).”
BackgroundMethodInfluentialConcise Review: Mesenchymal Tumors: When Stem Cells Go Mad
Mohseny, A. B., & Hogendoorn, P. C. W. (2011) · Stem Cells · doi:10.1002/stem.596 · Cited by 142
Xu, M.-H., Gao, X., Luo, D., Zhou, X., Xiong, W., & Liu, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087893 · Cited by 142
“In the majority of cases, tumor-infiltrating MSCs provide various functional aids to promote malignancy, ranging from structural support to creating a pre-metastatic environment [18,19].”
BackgroundChafe, S. C., Lou, Y., Sceneay, J., Vallejo, M., Hamilton, M. J., McDonald, P. C., Bennewith, K. L., Möller, A., & Dedhar, S. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3000 · Cited by 134
“Both CXCL10 and CCL5 have previously been implicated in breast cancer metastasis through the recruitment of bone marrow–derived mesenchymal stem cells, while a role for CCL5 in MDSC recruitment has also been suggested (10, 22, 23).”
BackgroundFrankenberger, C., Rabe, D., Bainer, R., Sankarasharma, D., Chada, K., Krausz, T., Gilad, Y., Becker, L., & Rosner, M. R. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3394 · Cited by 136
“Although the CCL5–CCR5 axis has been implicated in breast cancer metastasis, the role of macrophages in this process and the molecular and cellular mechanisms of action have been controversial (20, 27, 28).”
Myc Is a Metastasis Gene for Non-Small-Cell Lung Cancer
Rapp, U. R., Korn, C., Ceteci, F., Karreman, C., Luetkenhaus, K., Serafin, V., Zanucco, E., Castro, I., & Potapenko, T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006029 · Cited by 129
“A number of genes and gene products have been identified that positively or negatively affect the probability of established human tumor cell lines to metastasize [2,3,4].”
BackgroundStem cells in the treatment of diabetes mellitus — Focus on mesenchymal stem cells
Päth, G., Perakakis, N., Mantzoros, C. S., & Seufert, J. (2018) · Metabolism · doi:10.1016/j.metabol.2018.10.005 · Cited by 142
“Mechanistically, engineered MSC migrate to tumours where they become activated to express CCL5 [98].”
BackgroundOn the origin of cancer-associated fibroblasts
Anderberg, C., & Pietras, K. (2009) · Cell Cycle · doi:10.4161/cc.8.10.8557 · Cited by 121
Stem cells in gastroenterology and hepatology
Quante, M., & Wang, T. C. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.195 · Cited by 141
Mesenchymal Stem Cell-Induced DDR2 Mediates Stromal-Breast Cancer Interactions and Metastasis Growth
Gonzalez, M. E., Martin, E. E., Anwar, T., Arellano-Garcia, C., Medhora, N., Lama, A., Chen, Y.-C., Tanager, K. S., Yoon, E., Kidwell, K. M., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.079 · Cited by 133
“While studies have focused on the role of the primary tumor stroma in cancer progression (Barcellos-Hoff et al., 2013; Cuiffo et al., 2014; Karnoub et al., 2007; Li et al., 2012; Liu et al., 2011), the functions of the metastasis-associated stroma are largely unknown in part due to the lack of physiologically relevant…”
BackgroundInfluentialSansone, P., Berishaj, M., Rajasekhar, V. K., Ceccarelli, C., Chang, Q., Strillacci, A., Savini, C., Shapiro, L., Bowman, R. L., Mastroleo, C., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2129 · Cited by 137
The functional roles of exosomal long non-coding RNAs in cancer
Wang, M., Zhou, L., Yu, F., Zhang, Y., Li, P., & Wang, K. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03018-3 · Cited by 141
The multiple functional roles of mesenchymal stem cells in participating in treating liver diseases
Liu, W., Song, F., Ren, L., Guo, W., Wang, T., Feng, Y., Tang, L., & Li, K. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12482 · Cited by 139
“Several studies suggest that MSCs might promote tumour growth via transformation, suppression of the antitumour immune response, and direct trophic action on tumour cells [75, 76].”
BackgroundWang, L., Tang, C., Cao, H., Li, K., Pang, X., Zhong, L., Dang, W., Tang, H., Huang, Y., Wei, L., et al. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1056409 · Cited by 139
Vázquez, F., García-Ocaña, M., Galván, J. A., García–Martínez, J., García-Pravia, C., Menéndez‐Rodríguez, P., del Rey, C. G., Barneo, L., & Toyos, J. R. D. L. (2015) · Tumor Biology · doi:10.1007/s13277-015-3295-4 · Cited by 139
Mesenchymal stem cells as all-round supporters in a normal and neoplastic microenvironment
Hass, R., & Otte, A. (2012) · Cell Communication and Signaling · doi:10.1186/1478-811x-10-26 · Cited by 141
“onment [142, 143].”
Xiang, X., Niu, Y., Wang, Z.-H., Ye, L., Peng, W., & Zhou, Q. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2022.07.006 · Cited by 138
Orr, B. A., Riddick, A. C. P., Stewart, G. D., Anderson, R. A., Franco, O. E., Hayward, S. W., & Thomson, A. A. (2011) · Oncogene · doi:10.1038/onc.2011.312 · Cited by 138
“Stromal gene expression pattern predicts disease progression (Finak et al., 2008; Ma et al., 2009), while signalling from mesenchymal stem cells via CCL5 stimulates metastasis (Karnoub et al., 2007).”
BackgroundCambien, B., Richard, P., Karimdjee-Soilihi, B., Martini, V., Ferruà, B., Pitard, B., Schmid‐Antomarchi, H., & Schmid‐Alliana, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028842 · Cited by 138
“In breast cancer, in vivo CCL5 neutralization or CCR5 antagonism were shown to abrogate the MSC-induced metastasis of cancer cells thus implicating CCL5/CCR5 as a key axis in this malignancy [21].”
BackgroundMiyata, H., Yoshioka, A., Yamasaki, M., Nushijima, Y., Takiguchi, S., Fujiwara, Y., Nishida, T., Mano, M., Mori, M., & Doki, Y. (2009) · Cancer · doi:10.1002/cncr.24390 · Cited by 138
Zhang, Q., Yamaza, T., Kelly, A., Shi, S., Wang, S., Brown, J., Wang, L., French, S. W., Shi, S., & Le, A. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007798 · Cited by 140
“In response to the unique tumor microenvironment of chronic inflammation [77,78], BMMSCs may acquire the cancer-associated fibroblast (CAF) phenotype and subsequently promote tumor growth and metastasis via the production of pro-angiogenic and tumor stimulating paracrine factors [79,80].”
BackgroundHypoxia-Induced Secretion of TGF-β1 in Mesenchymal Stem Cell Promotes Breast Cancer Cell Progression
Hung, S.-P., Yang, M.-H., Tseng, K.-F., & Lee, O. K. (2013) · Cell Transplantation · doi:10.3727/096368912x657954 · Cited by 137
“reported that MSCs increase the metastatic potency of cancer cells through chemokine (C-C motif) ligand 5 (CCL5) secretion via MSC contact with nearby cancer cells (10), and our findings provide further evidence supporting the proposed effect of MSCs on cancer cell progression through a paracrine effect involving cyto…”
BackgroundMesenchymal stem cells: From regeneration to cancer
Li, P., Gong, Z., Shultz, L. D., & Ren, G. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.04.005 · Cited by 134
Mesenchymal Stem Cells in the Tumor Microenvironment
Atiya, H. I., Frisbie, L. G., Pressimone, C. A., & Coffman, L. G. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-37184-5_3 · Cited by 137
Pati, S., Khakoo, A. Y., Zhao, J., Jiménez, F., Gerber, M. H., Harting, M. T., Redell, J. B., Grill, R. J., Matsuo, Y., Guha, S., et al. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0013 · Cited by 137
“Although a number of previous reports suggest that the effect of MSCs are mediated locally through expression of factors that act in a paracrine manner [38,39], our current findings suggest the possibility that MSCs could also exert a systemic effect, possibly through the secretion of a soluble factor(s) induced by MS…”
Chen, Y., Zeng, C., Zhan, Y., Wang, H., Jiang, X., & Li, W. (2017) · Oncogene · doi:10.1038/onc.2017.100 · Cited by 119
Molecular characterisation of the tumour microenvironment in breast cancer
Hu, M., & Polyak, K. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.09.038 · Cited by 110
Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis
Kwak, T., Drews‐Elger, K., Ergonul, A. B., Miller, P. C., Braley, A. E., Hwang, G. H., Zhao, D., Besser, A., Yamamoto, Y., Yamamoto, H., et al. (2016) · Oncogene · doi:10.1038/onc.2016.324 · Cited by 137
Sjöberg, E., Meyrath, M., Milde, L., Herrera, M., Lövrot, J., Hägerstrand, D., Frings, O., Bartish, M., Rolny, C., Sonnhammer, E. L. L., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1294 · Cited by 135
“CCL5 secreted from bone marrow–derived mesenchymal cells, recruited to the breast tumor stroma,was identified a key player in promoting tumor cell invasion and development of metastasis in SCID mice (13).”
BackgroundDeciphering the role of stroma in pancreatic cancer
Waghray, M., Yalamanchili, M., Magliano, M. P. D., & Simeone, D. M. (2013) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328363affe · Cited by 124
Single-cell level co-culture platform for intercellular communication
Hong, S., Pan, Q., & Lee, L. P. (2012) · Integrative Biology · doi:10.1039/c2ib00166g · Cited by 122
The roles of tumor- and metastasis-promoting carcinoma-associated fibroblasts in human carcinomas
Mezawa, Y., & Orimo, A. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2471-1 · Cited by 138
“Interactions of CAFs or their progenitor MSCs with carcinoma cells in tumors also play substantial roles in promoting tumor cell invasion and metastasis (Chaturvedi et al. 2013; Dumont et al. 2013; Karnoub et al. 2007; Luga et al. 2012; Zhang et al. 2013).”
BackgroundHow Schwann cells facilitate cancer progression in nerves
Deborde, S., & Wong, R. J. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2578-x · Cited by 135
Cell membrane camouflaged nanoparticles: a new biomimetic platform for cancer photothermal therapy
Wu, M., Le, W., Mei, T., Wang, Y., Chen, B., Liu, Z., & Xue, C. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s200284 · Cited by 134
Cancer-Associated Fibroblasts: Versatile Players in the Tumor Microenvironment
Ganguly, D., Chandra, R., Karalis, J. D., Teke, M. E., Aguilera, T. A., Maddipati, R., Wachsmann, M., Ghersi, D., Siravegna, G., Zeh, H. J., et al. (2020) · Cancers · doi:10.3390/cancers12092652 · Cited by 136
Tumor metastasis: Mechanistic insights and therapeutic interventions
Liu, M., Yang, J., Xu, B.-S., & Zhang, X. (2021) · MedComm · doi:10.1002/mco2.100 · Cited by 136
Ohkouchi, S., Block, G. J., Katsha, A. M., Kanehira, M., Ebina, M., Kikuchi, T., Saijo, Y., Nukiwa, T., & Prockop, D. J. (2012) · Molecular Therapy · doi:10.1038/mt.2011.259 · Cited by 120
Chiavarina, B., Whitaker-Menezes, D., Martinez-Outschoorn, U. E., Witkiewicz, A. K., Birbe, R., Howell, A., Pestell, R. G., Smith, J., Daniel, R., Sotgia, F., et al. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.12.18703 · Cited by 128
“In particular, in vitro and in vivo studies have shown that breast and prostate cancer progression are highly dependent on cancer-associated fibroblasts (CAFs).(4,5) CAFs are known to support tumor growth(6) and may play a key role in the acquisition of drug resistance in tumor cells.”
BackgroundLjujic, B., Milovanovic, M., Volarevic, V., Murray, B., Bugarski, D., Przyborski, S., Arsenijevic, N., Lukic, M. L., & Stojkovic, M. (2013) · Scientific Reports · doi:10.1038/srep02298 · Cited by 115
“This is similar to Karnoub et al.(32) who reported that MSC treatment can induce a transient prometastatic effect on breast cancer cells but do not corroborate other studies which reported that MSC suppress tumor growth(37) and metastasis(38).”
ResultDevelopment of individualized anti-metastasis strategies by engineering nanomedicines
He, Q., Guo, S., Qian, Z., & Chen, X. S. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00511b · Cited by 133
Fujita, H., Ohuchida, K., Mizumoto, K., Nakata, K., Yu, J., Kayashima, T., Cui, L., Manabe, T., Ohtsuka, T., & Tanaka, M. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181dbf647 · Cited by 116
“Bone marrowY derived mesenchymal stem cells, which produce stromal myofibroblasts,(48) were reported to initiate the premetastatic niche(48,49) and promote metastasis.(50) Vonlaufen et al(47) demonstrated that cotransplantation of pancreatic cancer cells and PSCs into the pancreas of nude mice enhanced liver metastasi…”
BackgroundModulation of the Tumor Microenvironment for Cancer Treatment: A Biomaterials Approach
Adjei, I. M., & Sharma, B. (2015) · Journal of Functional Biomaterials · doi:10.3390/jfb6010081 · Cited by 133
“Recruited MSCs can produce cytokines, principally CCL5, which enhance the migration, invasion and metastasis of cancer cells [49,51].”
BackgroundA Biophysical Indicator of Vaso-occlusive Risk in Sickle Cell Disease
Wood, D. K., Soriano, A., Mahadevan, L., Higgins, J. M., & Bhatia, S. N. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3002738 · Cited by 120
“Even at the cellular scale, recent studies suggest new possibilities for biophysical markers, such as cell motility or cell deformability, as an important indicator of metastatic potential in cancer (14, 15) and other diseases (16, 17).”
Chan, T., Shaked, Y., & Tsai, K. K. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00688 · Cited by 132
“In breast cancer, the cancer cells stimulate the secretion of CCL-5 from MSCs, which acts in a paracrine fashion on the cancer cells to enhance their motility, invasion, and metastasis (15).”
BackgroundInfluentialThe role of toll-like receptor 4 in tumor microenvironment
Li, J., Yang, F., Wei, F., & Ren, X. (2017) · Oncotarget · doi:10.18632/oncotarget.19105 · Cited by 131
“As a type of tumor stromal cell, MSCs promote tumor growth and metastasis by secreting cytokines and chemokines in tumor microenvironment [76, 77].”
BackgroundThe mechanisms of cancer immunoescape and development of overcoming strategies
Yaguchi, T., Sumimoto, H., Kudo‐Saito, C., Tsukamoto, N., Ueda, R., Iwata‐Kajihara, T., Nishio, H., Kawamura, N., & Kawakami, Y. (2011) · International Journal of Hematology · doi:10.1007/s12185-011-0799-6 · Cited by 134
“When incorporated into tumor tissues, MSCs have anti-apoptotic effects on cancer cells, promote tumor vascularization by producing VEGF [51], and promote their invasion and metastases by producing CCL5 [ 52 ].”
Background3D Matrices for Anti-Cancer Drug Testing and Development
Gurski, L. A., Petrelli, N. J., Jia, X., & Farach-Carson, M. C. (2010) · Oncology Issues · doi:10.1080/10463356.2010.11883480 · Cited by 130
Niess, H., Bao, Q., Conrad, C., Zischek, C., Notohamiprodjo, M., Schwab, F., Schwarz, B., Huss, R., Jauch, K.-W., Nelson, P. J., et al. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e3182368c4f · Cited by 119
A regulatory cross‐talk between Vγ9Vδ2 T lymphocytes and mesenchymal stem cells
Martinet, L., Fleury‐Cappellesso, S., Gadelorge, M., Dietrich, G., Bourin, P., Fournié, J., & Poupot, R. (2009) · European Journal of Immunology · doi:10.1002/eji.200838812 · Cited by 98
Ha, G., Park, J. S., & Breuer, E.-K. Y. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.013 · Cited by 130
“S1) [49–60].”
Prockop, D. J., & Oh, J. Y. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24046 · Cited by 119
“Others indicated they enhanced propagation and even metastases of cancer cells [Karnoub et al., 2007].”
BackgroundRetroviral vector‐producing mesenchymal stem cells for targeted suicide cancer gene therapy
Uchibori, R., Okada, T., Ito, T., Urabe, M., Mizukami, H., Kume, A., & Ozawa, K. (2009) · The Journal of Gene Medicine · doi:10.1002/jgm.1313 · Cited by 128
Zhang, Y., Lv, D., Kim, H.-J., Kurt, R. A., Bu, W., Li, Y., & Ma, X. (2012) · Cell Research · doi:10.1038/cr.2012.178 · Cited by 129
β-Catenin–regulated myeloid cell adhesion and migration determine wound healing
Amini-Nik, S., Cambridge, E., Yu, W., Guo, A., Whetstone, H., Nadesan, P., Poon, R., Hinz, B., & Alman, B. A. (2014) · Journal of Clinical Investigation · doi:10.1172/jci62059 · Cited by 120
“Real-time PCR confirmed that cells with active β -catenin/Tcf signaling exhibited markedly higher expression of the macrophage markers F4/80, CD281, and CD204 compared with the Tcf-inactive population (Figure 1B).”
InfluentialAdvances in mesenchymal stem cell-mediated gene therapy for cancer
Dwyer, R. M., Khan, S., Barry, F. P., O'Brien, T., & Kerin, M. J. (2010) · Stem Cell Research & Therapy · doi:10.1186/scrt25 · Cited by 115
The physiology and pathology of the EMT: Meeting on the Epithelial–Mesenchymal Transition
Acloque, H., Thiery, J. P., & Nieto, M. A. (2008) · EMBO Reports · doi:10.1038/embor.2008.30 · Cited by 129
The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe
Kidd, S., Spaeth, E., Klopp, A., Andreeff, M., Hall, B., & Marini, F. (2008) · Cytotherapy · doi:10.1080/14653240802486517 · Cited by 128
The hallmarks of CAFs in cancer invasion
Atieh, Y., & Vignjevic, D. M. (2016) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2016.07.004 · Cited by 128
Metabolically activated adipose tissue macrophages link obesity to triple-negative breast cancer
Tiwari, P., Blank, A., Cui, C., Schoenfelt, K. Q., Zhou, G., Xu, Y., Khramtsova, G. F., Olopade, O. I., Shah, A. M., Khan, S. A., et al. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20181616 · Cited by 129
Tang, Y., & Weiss, S. J. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1280643 · Cited by 128
“linked to events ranging from tissue repair and cancer to fibrosis.(71-76) As Snail/Slug as well as YAP/TAZ can participate in all of these events,(7,42,43) we presume that the functional roles for the”
BackgroundPancreatic ductal adenocarcinoma progression is restrained by stromal matrix
Jiang, H., Torphy, R. J., Steiger, K., Hongo, H., Ritchie, A. J., Kriegsmann, M., Horst, D., Umetsu, S. E., Joseph, N. M., McGregor, K., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci136760 · Cited by 127
Preactivation of Human MSCs with TNF-α Enhances Tumor-Suppressive Activity
Lee, R. H., Yoon, N., Reneau, J. C., & Prockop, D. J. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.10.001 · Cited by 128
Mathew, E., Brannon, A. L., Del Vecchio, A., Garcia, P. E., Penny, M. K., Kane, K. T., Vinta, A., Buckanovich, R. J., & di Magliano, M. P. (2016) · Neoplasia · doi:10.1016/j.neo.2016.01.005 · Cited by 121
“In breast cancer, bone marrow–derived MSCs promote the metastasis of tumor cells through a CCL5-mediated effect [11].”
BackgroundLing, X., Marini, F. C., Konopleva, M. Y., Schober, W. D., Shi, Y., Burks, J. K., Clise-Dwyer, K., Wang, R., Zhang, W., Yuan, X., et al. (2010) · Cancer Microenvironment · doi:10.1007/s12307-010-0041-8 · Cited by 127
“ronment similar to that described in wound healing, which also induces MSC to specifically migrate to the wound (or site of inflammation) [40, 41 ].”
BackgroundMiRNA expression analysis of cancer-associated fibroblasts and normal fibroblasts in breast cancer
Zhao, L., Sun, Y., Hou, Y., Peng, Q., Wang, L., Luo, H., Tang, X., Zeng, Z., & Liu, M. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.08.005 · Cited by 126
“Carcinoma-associated fibroblasts (CAFs), commonly eferred to as myofibroblasts, are altered stromal resident fibrobasts and make up a significant portion of the tumor stroma (Mueller nd Fusenig, 2004; Mishra et al., 2008; Karnoub et al., 2007).”
BackgroundOrigin of carcinoma associated fibroblasts
Haviv, I., Polyak, K., Qiu, W., Hu, M., & Campbell, I. (2009) · Cell Cycle · doi:10.4161/cc.8.4.7669 · Cited by 114
Understanding the Role of ETS-Mediated Gene Regulation in Complex Biological Processes
Findlay, V. J., LaRue, A. C., Turner, D. P., Watson, P. M., & Watson, D. K. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407190-2.00001-0 · Cited by 125
Zhu, Y., Li, X., Wang, L., Hong, X., & Yang, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.988295 · Cited by 125
“In regard to breast cancer, both the Karnoub AE team and the Tan W team found that the chemokine CCL5 determines the process of recruiting CD4+CD25+ Treg cells to CAFs (43, 265).”
BackgroundDi, G.-H., Liu, Y., Lu, Y., Liu, J., Wu, C., & Duan, H.-F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113572 · Cited by 114
“Furthermore, the enhanced metastatic ability was dependent on paracrine factor CCL5 [15].”
BackgroundWang, Y., Liu, J., Jiang, Q., Deng, J., Xu, F., Chen, X., Cheng, F., Zhang, Y., Yao, Y., Xia, Z., et al. (2017) · Stem Cells · doi:10.1002/stem.2643 · Cited by 119
Xu, Q., Yuan, X., Liu, G., Black, K. L., & Yu, J. S. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0459 · Cited by 124
Mesenchymal Stem Cells in Tissue Growth and Repair
Kalinina, N., Sysoeva, V., Rubina, K. A., Parfenova, Y. V., & Va, T. (2011) · Acta Naturae · doi:10.32607/20758251-2011-3-4-30-37 · Cited by 124
Adipose-Derived Stem Cells in Radiotherapy Injury: A New Frontier
Shukla, L., Morrison, W. A., & Shayan, R. (2015) · Frontiers in Surgery · doi:10.3389/fsurg.2015.00001 · Cited by 115
Hussain, Z., Rahim, M. A., Jan, N., Shah, H., Rawas‐Qalaji, M., Khan, S., Sohail, M. F., Thu, H. E., Ramli, N. A., Sarfraz, R. M., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.05.018 · Cited by 123
Wang, C., Jiang, J., Ji, J., Cai, Q., Chen, X., Yu, Y., Zhu, Z., & Zhang, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-03031-1 · Cited by 118
Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review
Christodoulou, I., Goulielmaki, M., Devetzi, M., Panagiotidis, M., Koliakos, G., & Zoumpourlis, V. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1078-8 · Cited by 122
Metadata
- Authors
- Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Weinberg, Robert A.
- Venue
- Nature
- Published
- 2007-10-04
- Volume
- 449
- Issue
- 7162
- Pages
- 557-563
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2141815918
- Cited by
- 3,206
- References
- 36
- Citations by year
- 2026: 41 · 2025: 69 · 2024: 95 · 2023: 137 · 2022: 144 · 2021: 186 · 2020: 192 · 2019: 153 · 2018: 145 · 2017: 176 · 2016: 182 · 2015: 222 · 2014: 232 · 2013: 232 · 2012: 216
- FWCI
- 89.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (P50CA089393, R01CA116235)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Keywords
- mesenchymal stem cells, breast cancer metastasis, tumor stroma, RANTES, CCR5, paracrine signaling, tumor cell motility, tumor invasion, tumor microenvironment, bone marrow-derived stem cells, tumor xenografts
- MeSH terms
- Animals, Breast Neoplasms, Cell Movement, Fibroblasts, Humans, Lung Neoplasms, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasm Transplantation, Mice, SCID, Mice, Inbred NOD, Stromal Cells, Carcinoma, Ductal, Breast, Chemokine CCL5, Receptors, CCR5, Chemokines, CC, Paracrine Communication, Mesenchymal Stem Cell Transplantation, Cell Line, Tumor, Mice, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.